AR
Akshay Rakesh Chaudhary
About Akshay Rakesh Chaudhary
Data last updated:
Akshay Rakesh Chaudhary is a Director at Mehsana Next Parks Private Limited (since 2026) and Director at Anbuva Pharma Private Limited (since 2024). The companies operate in Chemicals and Materials.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Mar 2026 | 2025 | Active | ||
| Director | 06 Mar 2024 | 2022 | Active |
Board colleagues of Akshay Rakesh Chaudhary
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhimant Janak Bakshi | 07897159 | Mehsana Next Parks Private Limited | Additional Director |
| Prafulla Premchand Khinvasara | 07044639 | Mehsana Next Parks Private Limited | Additional Director |
| Ruchi Dilip Chaudhari | 03401552 | Mehsana Next Parks Private Limited | Director |
| Jagdish Madhavlal Chaudhary | 01687830 | Anbuva Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akshay Rakesh Chaudhary
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akshay Rakesh Chaudhary
Akshay Rakesh Chaudhary currently holds 2 directorships: Mehsana Next Parks Private Limited (Director, since 16 Mar 2026); Anbuva Pharma Private Limited (Director, since 06 Mar 2024).
Akshay Rakesh Chaudhary was first appointed on 06 Mar 2024 as Director at Anbuva Pharma Private Limited. The most recent appointment on record is 16 Mar 2026 at Mehsana Next Parks Private Limited.
The current boards of Akshay Rakesh Chaudhary's companies include Dhimant Janak Bakshi (Mehsana Next Parks Private Limited), Prafulla Premchand Khinvasara (Mehsana Next Parks Private Limited), Ruchi Dilip Chaudhari (Mehsana Next Parks Private Limited), Jagdish Madhavlal Chaudhary (Anbuva Pharma Private Limited).